UNSPSC 51263603: Alfuzosin hydrochloride

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C19H27N5O4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75046A1XTN, chemically known as 2-furancarboxamide, n-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-, monohydrochloride (+-)- but more generally known as alfuzosin hydrochloride, which bears US NIH Compound Identifier 71764. The base coompound, Alfuzosin, also comes in simple form.

UNSPSC 51263603 Alfuzosin hydrochloride is a Commodity code for a specific pharmaceutical product, but the recent state and local opportunities posted under this code show a substantial mismatch: Seminole County, Florida's IFB60459723LAS solicits Naloxone and drug deactivation systems for community health initiatives, while the Texas Health and Human Services Commission's RFI HHS0017013 explores direct-to-manufacturer prescription programs at the state level. Neither opportunity involves alfuzosin hydrochloride procurement. State and local governments show little relevant recent activity under this specific pharmaceutical commodity code.

The Seminole County IFB, due July 26, 2023, targets 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; vendors must include shipping costs, comply with drug-free workplace certification and E-Verify requirements, and maintain workers' compensation and commercial general liability insurance on a two-year initial term with one-year renewal option. The Texas RFI, issued by HHS on March 27, 2026, with a response deadline of April 3, 2026, seeks vendor capabilities for direct-to-manufacturer prescription contracting to improve fulfillment efficiency and cost management outside traditional pharmacy benefit manager and group purchasing organization channels. Neither solicitation relates to alfuzosin hydrochloride specifically, suggesting the code's tagging may reflect a data classification error or an upstream categorization mismatch rather than actual procurement demand for this pharmaceutical product at the state and local level.